Clinical Trials Directory

Trials / Completed

CompletedNCT00883233

Comparison of Four Different Regimens of Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in Acne Vulgaris

Efficacy and Safety Comparison of Four Different Regimens of Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
123 (actual)
Sponsor
Galderma R&D · Industry
Sex
All
Age
12 Years – 35 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the tolerability of 3 treatment regimens containing Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel with that of Adapalene 0.1% /Benzoyl Peroxide 2.5% Gel standard daily overnight application for 12 weeks in the treatment of acne vulgaris. The efficacy of the four treatment regimens will also be evaluated.

Conditions

Interventions

TypeNameDescription
DRUGAdapalene BPO Gel standard daily overnight applicationAdapalene 0.1% /Benzoyl Peroxide 2.5% Gel standard daily overnight application for 12 week
DRUGAdapalene-BPO 3-hour daily application before bedtimeAdapalene 0.1% / Benzoyl Peroxide 2.5% Gel 3-hour daily application before bedtime for first 4 weeks and then standard overnight daily application for the following 8 weeks
DRUGAdapalene-BPO Gel every other day applicationAdapalene 0.1% /Benzoyl Peroxide 2.5% Gel every other day application for the first 4 weeks and then standard overnight daily application for the following 8 weeks
DRUGAdapalene-BPO Gel standard+Cetaphil® Moisturizing LotionAdapalene 0.1% / Benzoyl Peroxide 2.5% Gel standard daily overnight application with Cetaphil® Moisturizing Lotion application at wake-up time for the first 4 weeks and then standard daily overnight application for the following 8 weeks

Timeline

Start date
2009-04-01
Primary completion
2009-09-01
Completion
2009-09-01
First posted
2009-04-17
Last updated
2021-02-18
Results posted
2010-12-08

Locations

2 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT00883233. Inclusion in this directory is not an endorsement.